Compound ID | 3446
Synonym(s): CJ-15801 | CJ15801
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Coenzyme A (CoA) synthesis inhibitor (mimics the native reaction intermediate inducing a tight-binding with enzyme) |
| Target Pathogen: | Only active against Staphylococcus aureus |
| Description: | Natural product from Seimatosporium sp.; an antimetabolite of the vitamin synthesis pathway |
| Institute where first reported: | Pfizer Pharmaceuticals, Inc. |
| Year first mentioned: | 2001 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|